Attached files
| file | filename |
|---|---|
| EX-99.3 - EX-99.3 - Biohaven Pharmaceutical Holding Co Ltd. | a17-20862_1ex99d3.htm |
| EX-99.2 - EX-99.2 - Biohaven Pharmaceutical Holding Co Ltd. | a17-20862_1ex99d2.htm |
| EX-99.1 - EX-99.1 - Biohaven Pharmaceutical Holding Co Ltd. | a17-20862_1ex99d1.htm |
| 8-K/A - 8-K/A - Biohaven Pharmaceutical Holding Co Ltd. | a17-20862_18ka.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-218193) of Biohaven Pharmaceutical Holding Company Ltd. of our report dated August 24, 2017 relating to the financial statements of Kleo Pharmaceuticals, Inc., which appears in this Current Report on Form 8-K/A of Biohaven Pharmaceutical Holding Company Ltd.
/s/ PricewaterhouseCoopers LLP
Hartford, Connecticut
August 24, 2017